Informal Innovators and Fostering More Access to the Patent System
Issues of “access” to medicines have been part of mainstream IP debates for many years now. Unfortunately, another glaring issue of “access” has not merited sufficient attention: namely that of access to the patent system itself. Quite surprising, given that this bottleneck ends up engendering more inequity, as it prevents poor “informal” innovators from partaking in the benefits offered by the patent system. Given that patents are a major “reputational” currency for new businesses these days, it is critical that […]
Informal Innovators and Fostering More Access to the Patent System Read More »